3D Cardiac Reconstruction
Advanced 3D reconstruction for heart chamber mapping and electrophysiology
Company profile
Company profile
RSIP Vision is an established leader in computer vision and medical image analysis R&D, founded and led by Ron Soferman. For over 25 years, the company has been at the forefront of medical imaging AI, developing custom software solutions that power medical devices and clinical applications used by industry-leading medical device companies. The company specializes in solving complex imaging challenges across multiple clinical fields including cardiology, orthopedics, gastroenterology, pulmonology, ophthalmology, ENT, urology, and surgical applications. Their technologies support various imaging modalities including CT, MRI, ultrasound, fluoroscopy, endoscopy, microscopy, and OCT. RSIP Vision employs a multidisciplinary team of distinguished engineers from physics, computer science, mathematics, biomedicine, and neuroscience backgrounds. Their approach spans the entire innovation lifecycle from concept development and prototype creation through implementation, productization, integration, validation, and regulatory support. The company's solutions are clinically proven and deployed in hundreds of applications currently in clinical use. Their technologies have contributed to joint replacement surgery, bronchoscopies, cardiac catheterization labs, and numerous other medical procedures. With offices spanning from Israel to Boston and San Francisco, RSIP Vision serves as a trusted R&D partner for medical device manufacturers seeking to integrate advanced AI and computer vision capabilities into their products.
Company description RSIP Vision official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Embedded deployment with recorded integration context.
Company milestones
Attending multiple major medical conferences in 2026 including AAO, NASS, MISS, DeviceTalks, AUA, SAGES, and AAOS. Expanded operations from Israel to Boston and San Francisco.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Advanced 3D reconstruction for heart chamber mapping and electrophysiology
AI-powered video analysis for endoscopy and surgical applications
Robust and accurate segmentation engines across all modalities and clinical fields
Automated analysis for microscopy with state-of-the-art accuracy
Comprehensive AI solutions for ophthalmic imaging and diagnostics
Precision computer vision for orthopedic surgical planning and navigation
Automated ultrasound image acquisition, quantification, and analysis
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
International journal of computer assisted radiology and surgery · Feb 1, 2025
The utility of a new method of movement therapy on responsiveness, movement, and emotional state in a psychogeriatric population: an exploratory study.Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · Mar 1, 2021
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Accurate patient-specific anatomy reconstruction for surgical planning
Cardiac ultrasound interpretation for non-expert users
Automation of surgical workflow analytics
FISH imaging platform for cell analysis
Developed AI approaches for challenging medical video analysis tasks using advanced deep learning methods
Successfully provided proof of concept solutions through short development cycles
Rapid development of head CT basic segmentation algorithm before product release
Algorithm successfully processes hundreds of CT scans in production use
3D reconstruction for improved mapping of electrical activity and anatomy of heart chambers
Developed innovative solutions for cardiac electrophysiology procedures
Proved out range of AI benefits for endoscopic video analysis application
Successfully demonstrated AI capabilities for video analysis
Robust nuclei segmentation and abnormality risk estimation for tightly clumped and overlapping cells
Integrated segmentation and risk estimation modules into production software
AI development for medical device innovation with transparent development process
Delivered novelty and capabilities to boost next-generation products on timeline
Automated generation of accurate 3D models of complex patient-specific anatomies from chest CT
Successfully deployed anatomical modeling capability for clinical use
Enhanced Digital Surgery Platform with algorithmic solutions for surgical applications
Delivered robust, clinically accurate, and quick algorithmic solutions
Integrated AI capabilities for automated cardiac ultrasound interpretation for non-expert users
Successfully deployed Auto-FAC and quality grading for cardiac ultrasound
05 · Leadership
Leadership profiles and professional links from the current Company record.
Ron Soferman
CEO
06 · Company updates
Recent articles published on RSIP Vision's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.